Index Performance
+21.12%
SCDI
+18.13%
IBB
+13.31%
DIA
+24.63%
QQQ
Overview
Description
To track the performance of clinical development organizations.
- TickerSCDI
- Inception Date05/31/2023
- WeightingEqual
- # of holdings12
What's inside?
Holdings
All holdings as of July 10, 2025
CSV download
CryoPort, Inc. (CYRX) | 9.31% | $376.53M | -24.82% | 37.87% | 1.58 |
Charles River Laboratories International, Inc. (CRL) | 8.76% | $8.04B | -2.71% | 27.93% | 2.66 |
Evotec SE (EVO) | 8.75% | $1.50B | -7.09% | 13.61% | 1.54 |
Bio-Rad Laboratories, Inc. (BIO) | 8.66% | $7.08B | -4.16% | 53.06% | 2.56 |
Thermo Fisher Scientific, Inc. (TMO) | 8.54% | $162.60B | 0.18% | 40.96% | 5.08 |
IQVIA Holdings, Inc. (IQV) | 8.44% | $28.64B | 2.43% | 27.02% | 2.83 |
West Pharmaceutical Services, Inc. (WST) | 8.38% | $16.47B | 0.42% | 33.33% | 5.61 |
Medpace Holdings, Inc. (MEDP) | 8.37% | $9.43B | 9.30% | 30.69% | 4.27 |
ICON plc (ICLR) | 8.19% | $12.28B | -4.26% | 23.12% | 2.10 |
Veeva Systems, Inc. (VEEV) | 7.94% | $46.02B | 16.71% | 76.73% | 11.51 |
Fortrea Holdings, Inc. (FTRE) | 7.82% | $476.93M | -1.63% | 14.89% | 0.69 |
Harvard Bioscience, Inc. (HBIO) | 6.82% | $20.32M | -11.17% | 50.63% | 0.70 |
Market data by FactSet